Boston Biotech Business Development Conference 2014

The Boston Biotech Business Development Conference is a networking forum for industry professionals offering exclusive access to the key decision makers who influence deal making and investment in the life sciences. Attendees will gain insights from presentations and panels featuring business development decision-makers from several of the world's leading pharmaceutical and biotechnology companies, on the current and future outlook for licensing, M&A and other business development activities in the life sciences sector. In between learning what it takes to get a deal done in biotech, the Business Development Conference offers opportunities throughout the day to network one-on-one with the industry's top deal makers - senior executives from biotech and pharma, leaders from Wall Street and venture capitalists. Goodwin Procter partner, Kingsley Taft, will moderate a panel discussion on the recent Alnylam-Genzyme Deal.